drug discovery

What excites Steve Jackson is understanding how biology works and why it sometimes goes wrong. But what galvanises him is knowing there are people...

Researchers have used artificial intelligence techniques to massively accelerate the search for Parkinson’s disease treatments.

The facility, based at the Milner Therapeutics Institute, will support the discovery of new medicines and diagnostics for chronic diseases by...

Researchers have developed a method to identify new targets for human disease, including neurodegenerative conditions such as Alzheimer’s disease.

A University of Cambridge spin-out company from the Cavendish Laboratory, combines materials engineering and cell biology to help biopharma companies...

Cambridge's Experimental Medicine Initiative, working with AstraZeneca and GSK, is training specialists who can work out at an earlier stage of...

Professor Steve Jackson talks about drug discovery, serial entrepreneurship and the enterprising mindset.

Cambridge scientists have identified 200 approved drugs predicted to work against COVID-19 – of which only 40 are currently being tested in COVID-19...